Lymphatic mapping of the neck in oral cavity malignancies using ICG-nanocolloid

Lymphatic mapping of the neck in oral cavity malignancies using ICG-nanocolloid - Lymphatic mapping of the neck using ICG-nanocolloid

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41880

Enrollment

Registered

2015-03-11

Start date

2015-04-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hoofd-hals oncologie: mondholtetumoren oral cavity carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients >= 18 years; Patients with T1-T4 oral cavity tumor; Patients scheduled for commando resection or transoral resection with a subsequent elective or therapeutic neck dissection.

Exclusion criteria

Exclusion criteria: Patients who have received prior surgical treatment or radiation therapy to the neck; Hyperthyroid or thyroidal adenoma; History of iodine allergy; Severe kidney insufficiency.

Design outcomes

Primary

Measure	Time frame
Identification of the lymphatic drainage pattern of oral cavity tumors	—

Secondary

Measure	Time frame
- Determination of the extension of the lymphatic drainage pattern. - Identificaiton of tumor-postitive lymph nodes. - Analysis of the rerouting phenomenon (in case lymph node metastasis are found).	—

Countries

Netherlands

Outcome results